WO2000005255A3 - Anti-inflammatory compounds - Google Patents

Anti-inflammatory compounds Download PDF

Info

Publication number
WO2000005255A3
WO2000005255A3 PCT/GB1999/002391 GB9902391W WO0005255A3 WO 2000005255 A3 WO2000005255 A3 WO 2000005255A3 GB 9902391 W GB9902391 W GB 9902391W WO 0005255 A3 WO0005255 A3 WO 0005255A3
Authority
WO
WIPO (PCT)
Prior art keywords
inflammatory compounds
compound
amino acid
acid sequence
eqeyvqtv
Prior art date
Application number
PCT/GB1999/002391
Other languages
French (fr)
Other versions
WO2000005255A2 (en
Inventor
Mauro Perretti
Roderick Flower
Original Assignee
William Harvey Research Limite
Mauro Perretti
Roderick Flower
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William Harvey Research Limite, Mauro Perretti, Roderick Flower filed Critical William Harvey Research Limite
Priority to AU50559/99A priority Critical patent/AU5055999A/en
Priority to EP99934941A priority patent/EP1100821B1/en
Priority to DE69930854T priority patent/DE69930854T2/en
Publication of WO2000005255A2 publication Critical patent/WO2000005255A2/en
Publication of WO2000005255A3 publication Critical patent/WO2000005255A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A compound comprising the amino acid sequence AMVSE, wherein said compound does not comprise the amino acid sequence EQEYVQTV. The compound is useful as an anti-inflammatory agent.
PCT/GB1999/002391 1998-07-24 1999-07-22 Anti-inflammatory compounds WO2000005255A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AU50559/99A AU5055999A (en) 1998-07-24 1999-07-22 Anti-inflammatory compounds
EP99934941A EP1100821B1 (en) 1998-07-24 1999-07-22 Anti-inflammatory compounds derived from lipocortin-1
DE69930854T DE69930854T2 (en) 1998-07-24 1999-07-22 DERIVED FROM LIPOCORTIN-1 DERIVED INFLAMMATORY ACTIVE SUBSTANCES

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9816235.7 1998-07-24
GBGB9816235.7A GB9816235D0 (en) 1998-07-24 1998-07-24 Anti-inflammatory compounds

Publications (2)

Publication Number Publication Date
WO2000005255A2 WO2000005255A2 (en) 2000-02-03
WO2000005255A3 true WO2000005255A3 (en) 2000-04-27

Family

ID=10836178

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/002391 WO2000005255A2 (en) 1998-07-24 1999-07-22 Anti-inflammatory compounds

Country Status (9)

Country Link
EP (1) EP1100821B1 (en)
AT (1) ATE323105T1 (en)
AU (1) AU5055999A (en)
DE (1) DE69930854T2 (en)
DK (1) DK1100821T3 (en)
ES (1) ES2263280T3 (en)
GB (1) GB9816235D0 (en)
PT (1) PT1100821E (en)
WO (1) WO2000005255A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100411828B1 (en) * 2001-04-21 2003-12-24 김수열 Novel anti-inflammatory synthetic peptides

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950646A (en) * 1985-01-10 1990-08-21 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptides

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950646A (en) * 1985-01-10 1990-08-21 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human lipocortin-like polypeptides

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CROXTALL J D ET AL.: "N-TERMINAL PEPTIDE FRAGMENTS OF LIPOCORTIN-1 INHIBIT A549 CELL GROWTH AND BLOCK EGF-INDUCED STIMULATION OF PROLIFERATION", INTERNATIONAL JOURNAL OF CANCER (1993 APR 22) 54 (1) 153-8, XP000876677 *
LIM L H ET AL.: "PROMOTING DETACHMENT OF NEUTROPHILS ADHERENT TO MURINE POSTCAPILLARY VENULES TO CONTROL INFLAMMATION EFFECT OF LIPOCORTIN 1", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (1998 NOV 24) 95 (24) 14535-9, XP002130358 *
PERRETTI M ET AL.: "LIPOCORTIN-1 FRAGMENTS INHIBIT NEUTROPHIL ACCUMULATION AND NEUTROPHIL-DEPENDENT EDEMA IN THE MOUSE A QUALITATIVE COMPARISON WITH AN ANTI-CD11B MONOCLONAL ANTIBODY", JOURNAL OF IMMUNOLOGY (1993 OCT 15) 151 (8) 4306-14, XP002130360 *

Also Published As

Publication number Publication date
DE69930854D1 (en) 2006-05-24
DK1100821T3 (en) 2006-08-14
EP1100821A2 (en) 2001-05-23
PT1100821E (en) 2006-08-31
AU5055999A (en) 2000-02-14
DE69930854T2 (en) 2006-11-23
EP1100821B1 (en) 2006-04-12
ES2263280T3 (en) 2006-12-01
WO2000005255A2 (en) 2000-02-03
ATE323105T1 (en) 2006-04-15
GB9816235D0 (en) 1998-09-23

Similar Documents

Publication Publication Date Title
CA2245124A1 (en) Fungicidal 2-methoxybenzophenones
WO1999064047A8 (en) Novel antiviral compounds
CA2312493A1 (en) Novel suppository form comprising an acid-labile active compound
AU732211C (en) Novel compound
HK1043127A1 (en) Compounds useful as anti-inflammatory agents.
AUPP796798A0 (en) New compound
AP9901552A0 (en) Sulfonic acid or sulfonylamino N- (heteroaralkyl)- azaheterocyclamide compounds
AUPP999799A0 (en) New compound
ZA99873B (en) Novel dihydroxyhexanoic acid derivatives.
AU3841499A (en) Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
AUPQ441499A0 (en) Novel compound
AU4218997A (en) 4-substituted-2,7-dideoxy-7-fluoro-2,3-didehydro-sialic acid compounds
AU1488001A (en) Stabilized thyroxine compounds
ZA992899B (en) Novel compound.
AUPP549998A0 (en) New compound
WO2000005255A3 (en) Anti-inflammatory compounds
ID23784A (en) THE PROCESS OF THE MAKING OF THE ALKOXSIFURAMAMINA DOWN, THE COMPOUND OBTAINED BY THIS PROCESS, AND THE USE OF THESE COMPOUNDS.
CA2244142A1 (en) Antifungal compound from hormonema sp.
AU1558200A (en) 1-hydroxy-3-sulfonoalkane-1,1-diphosphonous acids
ZA989954B (en) Process for the manufacture of an organic compound.
AU759012C (en) Amino acid sequence
AUPP377198A0 (en) Novel compound WF00144
AU5055699A (en) Compound storage
AU2002233181A1 (en) Novel, 2,5-diazabicyclo[2.2.1]heptane derivatives
AU6353599A (en) Compound

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1999934941

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999934941

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1999934941

Country of ref document: EP